From August 17 to 20, the 18th Health Industry Ecological Platform  (CPEO Summit) was grandly held in Boao, Hainan, where authoritative brand awards of great industry interest were announced. JumpCan Pharmaceutical's exclusive formulation product Pudilan Xiaoyan Oral Liquid  and exclusive variety Xiao'er Chiqiao Qingre Granules (Tongpei) were both honored on the "2025 Healthy China · Brand List" and the "2025 Healthy China · Brand Value List", reflecting their continuously rising brand value.

 

This year's summit brought together over 8,000 leaders and elites in the health sector, including a "super think tank" composed of academicians from the Chinese Academy of Sciences and the Chinese Academy of Engineering, as well as leading companies and institutions in pharmaceuticals, commerce, capital, R&D, technology, healthcare, and health services, providing forward-looking and systematic ideas and information exchange for the industry.

 

The "2025 Health Industry Brand List" is based on evaluations across multiple dimensions such as product value, market value, and user reputation, comprehensively, objectively, and authentically reflecting a product's brand strength in the health industry. Pudilan Xiaoyan Oral Liquid and Tongpei were selected for the list due to their excellent product quality, proven efficacy, and widespread consumer trust.

 

Additionally, the top 50 pharmaceutical brands from the "2025 Healthy China · Brand List" were selected to form the "2025 Healthy China · Brand Value List". Pudilan Xiaoyan Oral Liquid and Tongpei, as leading brands, were included on this list, with their brand advantages and market value receiving authoritative recognition, demonstrating their comprehensive competitiveness in the health sector.

 

Pudilan Xiaoyan Oral Liquid

 

As a representative heat-clearing and detoxifying traditional Chinese medicine product suitable for both children and adults, Pudilan Xiaoyan Oral Liquid has consistently ranked among the top brands in the traditional Chinese medicine market for heat-clearing and detoxification in urban retail pharmacies, urban public hospitals, and online e-commerce platforms in China for many years.

 

It has repeatedly won awards such as the "China Pharmacy Staff's Most Recommended Brand Award", "Most Popular Star Product in Pharmacies", "Best-Selling Brand in China's Pharmaceutical Retail Market", and "China Pharmacy Selected Brand 'Cold Category'". It has also been honored with titles like "Healthy China Top Ten Best-Selling Drug Brands" and "Family Medication Recommended Product", and has been listed on the "China Pharmaceutical · Brand List" and "Clinical Value Traditional Chinese Medicine Brand List", receiving high praise from doctors, pharmacists, and consumers.

 

In 2024, it was approved as a dual-status drug (both prescription and over-the-counter), allowing consumers to purchase the OTC version of Pudilan Xiaoyan Oral Liquid directly from pharmacies without a prescription, further enhancing medication convenience and accessibility. Additionally, the Pudilan series has launched an efficacy toothpaste infused with Pudilan's active essence to support daily oral health.

 

 

Xiao'er Chiqiao Qingre Granules (Tongpei)

 

Xiao'er Chiqiao Qingre Granules (Tongpei) is based on a proven formula from over 50 years of medical practice by Professor Li Shaochuan, one of China’s first renowned veteran traditional Chinese medicine physicians, and is one of the representative medications for pediatric colds.

 

In 2024, it ranked among the top in market share for pediatric cold traditional Chinese medicines in urban public hospitals, retail pharmacies, and online e-commerce platforms in China. It has been honored with awards such as "Healthy China · Most Recommended Children's Drug Brand by Parents", "Best-Selling Brand in China's Pharmaceutical Retail Market", "Most Popular Star Product in Pharmacies", "China Pharmacy Selected Brand 'Children's Category'" and "Most Recognized Pediatric Brand by Primary Care Doctors". It has also been consistently listed on the "Clinical Value Traditional Chinese Medicine Brand List" and "China Pharmaceutical · Brand List", earning widespread trust from retail pharmacies, doctors, and parents.

 

In 2023, Xiao'er Chiqiao Qingre Syrup (K-tonpei) was approved for market launch, becoming the first improved traditional Chinese medicine new drug marketed since the implementation of the new Drug Registration Management Measures. The syrup formulation further meets the diverse medication needs of children and enhances the patient experience.

 

 

Honors are both an incentive and a responsibility. Guided by its purpose of "Build a joyful and vibrant life together", JumpCan Pharmaceutical remains committed to product quality, strengthening product layout, brand building, and channel expansion. Driven by market demand, the company aims to build a differentiated health product matrix. In the future, JumpCan Pharmaceutical will continue to develop more branded products that benefit patients, leverage the momentum of best-selling brands, elevate potential brands to new heights, provide consumers with multi-dimensional health upgrade experiences, create greater value in the health sector, and contribute to the Healthy China strategy.